J P Laboratories Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 5.00 M
- Company Age 26 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.70 M
- Revenue Growth -98.92%
- Profit Growth -98.99%
- Ebitda -99.09%
- Net Worth -98.94%
- Total Assets -98.89%
About J P Laboratories
J P Laboratories Private Limited (JPLPL) is a Private Limited Indian Non-Government Company incorporated in India on 21 May 1998 and has a history of 26 years and nine months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹5.70 M.
Tulsi Pawar and Shiv Pawar serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U73100PN1998PTC012528
- Company No.
012528
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 May 1998
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at J P Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tulsi Pawar  | Managing Director | 30-Sep-2004 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shiv Pawar | Additional Director | 09-Oct-2024 | Current |
Financial Performance of J P Laboratories.
J P Laboratories Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 98.92% decrease. The company also saw a substantial fall in profitability, with a 98.99% decrease in profit. The company's net worth observed a substantial decline by a decrease of 98.94%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of J P Laboratories?
Unlock access to J P Laboratories's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vetcorr Biolabs Private LimitedTulsi Pawar is a mutual person
Charges (Loans)
₹5.70 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of Maharashtra : 0.57 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Oct 2001 | Bank Of Maharashtra | ₹5.70 M | Open |
How Many Employees Work at J P Laboratories?
J P Laboratories has a workforce of 29 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of J P Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped J P Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
